A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo
- PMID: 16847214
- DOI: 10.1001/archderm.142.7.927
A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
